CELLS ORIGINATING FROM LIVER

Brand Owner (click to sort) Address Description
HEPASTEM Promethera Therapeutics, Société anonyme Rue Granbonpré 11 B-1435 Mont-Saint-Guibert Belgium Cells originating from the liver, for medical, clinical or veterinary use, in particular liver stem cells or progenitor cells; pharmaceutical preparations for the treatment of liver diseases that require cell therapy medicinal products;Biomedical services for diagnosing and treating liver disease in relation to the testing of biological samples to determine the presence and activity of liver cells, in particular, liver stem cells and progenitor cells; medical and veterinary services for the isolation, analysis, processing, and administration of cells originating from the liver and in particular, liver stem cells and progenitor cells for diagnosing and treating liver disease;Scientific and biotechnological medical research for the pharmaceutical and health care industry relating to development of new medicinal products for cell therapy; scientific and biotechnological medical research for the pharmaceutical and healthcare industry relating to the new product design, validation in the form of quality control, and development of application methods for using cells, in particular, liver stem cells and progenitor cells; development of methods for storage and transport of cells, in particular, liver stem cells and progenitor cells;
HEPASTEM Promethera Biosciences Naamloze vennootschap Watson & Crick Hill, Rue Granbonpré 11, B-1435 Mont-Saint-Gui Belgium Cells originating from the liver, for medical, clinical or veterinary use, in particular liver stem cells or progenitor cells; pharmaceutical preparations for the treatment of liver diseases that require cell therapy medicinal products;Biomedical services for diagnosing and treating liver disease in relation to the testing of biological samples to determine the presence and activity of liver cells, in particular, liver stem cells and progenitor cells; medical and veterinary services for the isolation, analysis, processing, and administration of cells originating from the liver and in particular, liver stem cells and progenitor cells for diagnosing and treating liver disease;Scientific and biotechnological medical research for the pharmaceutical and health care industry relating to development of new medicinal products for cell therapy; scientific and biotechnological medical research for the pharmaceutical and healthcare industry relating to the new product design, validation in the form of quality control, and development of application methods for using cells, in particular, liver stem cells and progenitor cells; development of methods for storage and transport of cells, in particular, liver stem cells and progenitor cells;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides compositions and methods for selectively inhibiting the proliferation of stellate cells, which are important for the development of liver fibrosis upon liver injury. The invention describes conditioned media from immortalized hepatocytes as containing a death factor that induces apoptosis of activated liver stellate cells. This pro-apoptotic activity is shown to be associated with an 80 kDa protein, which is associated with a fetuin peptide sequence and an albumin peptide sequence.